In Brief: Children's Advil
This article was originally published in The Tan Sheet
Executive Summary
Children's Advil: Receives OTC marketing approval on June 28 for temporary relief of fever and minor aches and pains due to colds, flu, sore throat, headache, and toothache for children ages 2-11. The pediatric suspension formula has been "approvable" since April 25. Whitehall-Robins has not announced a launch date; however, the company will likely work quickly since McNeil's new Children's Motrin Drops and Junior Strength Motrin Caplets are scheduled to hit stores in August ("The Tan Sheet" June 17, p. 1)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning